Williamson K. International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease. PS-134.
Impact van ‘single-room contact precautions’ op acquisitie en transmissie van MDR 'E. coli'
mrt 2019 | Bacteriële infecties